Linda Rasooly

Title: Celebrating the Innovations of Linda Rasooly in Cancer Treatment

Introduction

Linda Rasooly, an innovative inventor hailing from Jerusalem, IL, has made significant strides in the field of cancer treatment. She holds a patent that presents a unique approach for combating tumors, showcasing her dedication to advancing medical science.

Latest Patents

Rasooly's notable patent, titled "Compositions of NDV and methods of use thereof for treatment of cancer," reveals groundbreaking methods for inducing tumor regression. The invention involves administering a pharmaceutical composition that includes a lentogenic strain of Newcastle disease virus (NDV). Specifically, the clonal strain of NDV known as NDV HUJ is highlighted for its efficacy in treating tumors, particularly in patients who do not respond to conventional anti-cancer therapies.

Career Highlights

Throughout her career, Linda has aligned herself with reputable organizations, most notably the Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Theravir Management L.P. Her work in these institutions has propelled her research and innovation in the medical field, particularly in onco-virology.

Collaborations

Collaborating with esteemed professionals such as Zichria Zakay-Rones and Amos Panet, Rasooly has built a robust network that enhances her research and development efforts. These partnerships have been crucial for advancing her inventions and contributing to the broader scientific community.

Conclusion

Linda Rasooly's contributions to cancer treatment through her innovative patent embody her commitment to finding solutions for patients with challenging medical conditions. Her work remains a beacon of hope for many, showcasing the potential of innovative science in transforming healthcare.